Niemann-Pick Disease Type C (NPDC) by Mutation of NPC1 and NPC2: Aberrant Lysosomal Cholesterol Trafficking and Oxidative Stress
Open Access
- 21 November 2023
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 12 (12) , 2021
Abstract
Cholesterol trafficking is initiated by the endocytic pathway and transported from endo/lysosomes to other intracellular organelles. Deficiencies in cholesterol-sensing and binding proteins NPC1 and NPC2 induce accumulation in lysosomes and the malfunction of trafficking to other organelles. Each organelle possesses regulatory factors to induce cholesterol trafficking. The mutation of NPC1 and NPC2 genes induces Niemann-Pick disease type C (NPDC), which is a hereditary disease and causes progressive neurodegeneration, developmental disability, hypotonia, and ataxia. Oxidative stress induces damage in NPDC-related intracellular organelles. Although studies on the relationship between NPDC and oxidation are relatively rare, several studies have reported the therapeutic potential of antioxidants in treating NPDC. Investigating antioxidant drugs to relieve oxidative stress and cholesterol accumulation is suggested to be a powerful tool for developing treatments for NPDC. Understanding NPDC provides challenging issues in understanding the oxidative stress–lysosome metabolism of the lipid axis. Thus, we elucidated the relationship between complexes of intracellular organelles and NPDC to develop our knowledge and suggested potential antioxidant reagents for NPDC therapy.Keywords
Funding Information
- National Research Foundation of Korea (NRF) (NRF-2022R1A2C1003890: JHH)
- Korean government (NRF-2022R1A2C1003890: JHH)
This publication has 139 references indexed in Scilit:
- Biology of the Heat Shock Response and Protein Chaperones: Budding Yeast (Saccharomyces cerevisiae) as a Model SystemMicrobiology and Molecular Biology Reviews, 2012
- Oxidative stress in Niemann–Pick disease, type CMolecular Genetics and Metabolism, 2010
- Adenovirus RID-α activates an autonomous cholesterol regulatory mechanism that rescues defects linked to Niemann-Pick disease type CJournal of Cell Biology, 2009
- Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7–RILP–p150Glued and late endosome positioningJournal of Cell Biology, 2009
- Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of CholesterolCell, 2009
- Adenovirus RIDα regulates endosome maturation by mimicking GTP-Rab7Journal of Cell Biology, 2007
- Annexin A6‐Induced Alterations in Cholesterol Transport and Caveolin Export from the Golgi ComplexTraffic, 2007
- Activation of endosomal dynein motors by stepwise assembly of Rab7–RILP–p150Glued, ORP1L, and the receptor βlll spectrinJournal of Cell Biology, 2007
- Protein Sensors for Membrane SterolsCell, 2006
- Vitamin E as an in Vitro and in Vivo AntioxidantaAnnals of the New York Academy of Sciences, 1989